Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,734 across all filing types
Latest filing 2021-10-26 Regulatory Filings
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
澄清生技投資第一站110/10/25網站報導
Regulatory Filings Classification · 95% confidence The document is a clarification statement issued by the company 美時 (Mei Shi Chemical Pharmaceutical Co., Ltd.) regarding a media report about their product and market activities. It includes factual clarifications about licensing, FDA approvals, and product launch timelines. The document is short (1669 characters) and serves as a public announcement to clarify misinformation rather than a detailed financial report or regulatory filing. It does not contain financial statements, management discussion, or detailed report data. It is a regulatory announcement clarifying facts to the public and investors, fitting best under Regulatory Filings (RNS) as a general regulatory announcement and clarification.
2021-10-26 Chinese
110年09月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings and changes in shareholdings by insiders, including directors, managers, and other key personnel. It includes data on shares held, increases, decreases, and trust shares. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of it being a full financial report, earnings release, or management discussion. The document is not a brief announcement but a detailed disclosure of insider shareholdings. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is sufficient and contains substantive data on insider holdings and transactions. Therefore, the appropriate classification is DIRS.
2021-10-14 Chinese
110年09月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings and pledged shares by company insiders, including directors, independent directors, general managers, and other executives. It lists the number of shares held, pledged shares, and related percentages. The content focuses on insider shareholdings and pledges rather than financial results, management changes, or meeting materials. This matches the definition of a Director's Dealing report, which covers personal share transactions or holdings by company directors and executives. The document length is 3653 characters, which is consistent with a detailed insider shareholding disclosure rather than a brief announcement or a full financial report. Therefore, the appropriate classification is Director's Dealing (DIRS).
2021-10-14 Chinese
110年9月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company (美時) providing information about fund loans and endorsement guarantees for the current and previous months. It contains tabular data on financial limits and balances but does not include comprehensive financial statements or detailed analysis. The document length is short (619 characters), and it appears to be a regulatory disclosure rather than a full report. There is no indication of an annual or interim report, audit report, or earnings release. The content fits best as a general regulatory announcement or compliance filing. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2021-10-12 Chinese
110年9月營業收入
Fund Information / Factsheet Classification · 85% confidence The document is a summarized revenue report from a listed company, showing monthly and cumulative net operating revenue figures with comparisons to the previous year. It includes notes on accounting standards (IFRS) and reporting practices. The document length is short (779 characters) and it primarily provides financial summary data without detailed financial statements or management discussion. It does not appear to be a full Annual Report, Interim Report, or Earnings Release. It is more of a brief financial summary or factsheet. Given the concise nature and summary format, the best fitting category is Fund Information / Factsheet (FS).
2021-10-12 Chinese
代重要子公司Alvogen Korea Holdings Ltd.公告董事當選 名單
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the election and changes of directors at a subsidiary company, Alvogen Korea Holdings Ltd. It details the names, positions, and terms of directors, including the reason for change (term expiration). There is no financial data, no report attached or referenced, and no mention of financial results or corporate governance policies beyond director changes. This fits the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2021-09-30 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.